| COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. | ![]() |
University of Cambridge > Talks.cam > Cambridge Immunology Network Seminar Series > Harnessing NK cell metabolism for cancer immunotherapy
Harnessing NK cell metabolism for cancer immunotherapyAdd to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Liat Churley. This Cambridge Immunology Network Seminar will take place on Thursday 4 December 2025, starting at 4:00pm, CRUK Lecture Theatre Speaker: Clair Gardiner, Professor in Immunology, School of Biochemistry and Immunology, Trinity College Dublin Title: “Harnessing NK cell metabolism for cancer immunotherapy” Short Bio: Professor Clair Gardiner is a Prof. in Immunology at Trinity College Dublin, Ireland. Based in the School of Biochemistry and Immunology since 2002, she is the Head of the Discipline of Immunology. Along with teaching and other admin duties, Prof. Gardiner has an active and dynamic research lab. She is an internationally recognized leader in the field of natural killer (NK) cell biology. Her research focuses on understanding how NK cell metabolism and signalling influence immune responses in cancer and immunotherapy. Over the past ten years, her group has made key contributions to elucidating the metabolic regulation of NK cell function, including the first ever paper published on human NK cell metabolism. Using patient cohorts from a variety of cancer types, the group seek to understand the mechanisms of NK cell metabolic dysregulation in cancer patients, understanding the impact of the TME on circulating NK cells and to translate these insights toward improving cancer immunotherapy. With over 60 peer-reviewed publications in leading journals including JITC , PNAS, Journal of Immunology, and Gut, Professor Gardiner’s work has been cited more than 3200 times. Her recent studies have uncovered how metabolic pathways—including those regulated by TGF β and PKM2 —shape NK cell responses in cancer, advancing the field of immunometabolism. Host: Maike de la Roche, CRUK Refreshments will be available following the seminar. This talk is part of the Cambridge Immunology Network Seminar Series series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsCAPE-CIKC Advanced Technology Lectures Cambridge Realist Workshop Centre for Family Research 2011 ArchiveOther talksSpectral gaps for random Schreier graphs Multivalent recombinant vaccines based on the bacterial Outer Membrane Vesicles (OMV) platform SerialKVM - the cheapest Software KVM The curious case of metal-poor DLAs at cosmic noon Welcome The early cometary bombardment of the early Earth and rocky exoplanets |